Ohm Laboratories Recalls Equaline Loratadine Tablets for Assay Failure
Ohm Laboratories is recalling Equaline loratadine tablets because they failed potency testing. Consumers should stop using the product and return it to the pharmacy.
- Product
- Equaline Original Prescription Strength, loratadine orally disintegrating tablets, USP, 10 mg, packaged in a) 10-count tablets per box, NDC 41163-528-69, UPC 0 4116347138 2; and b) 30-count tablets per box, NDC 41163-528-31, UPC 0 4116346654 8; Distributed by: Supervalu Inc. Eden
- Category
- Drug
- Distribution
- Distributed nationwide